In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From ratiopharm

Basilea Snaps Up Another Antibiotics Program As Pipeline Swells

The company has bagged a preclinical program from struggling Swiss biotech Spexis for $2.3m upfront, its fourth deal in as many months.

Deals Infectious Diseases

Finance Watch: The Rush To End 2023 With Fresh VC Cash For Biopharma

Private Company Edition: Playground’s third fund has $410m for tech, including biotech, Pivotal Life Sciences closed its second fund with $389m and Chugai will invest $200m through its new fund. Also, Tome launched with $213m, Sudo raised a $116m series B and Odyssey closed a $101m in series C.

Financing Innovation

France's Pharnext Undone By Placebo Effect

The Paris-based biotech's Charcot-Marie-Tooth disease drug falls short in Phase III.

Clinical Trials Business Strategies

Deal Watch: Graphite Exits Via Reverse Merger With Presbyopia Specialist LENZ

Plus deals involving Abliva/Owl, Selecta/Cartesian, Novo Nordisk/Genevant, AbbVie/Aldeyra and more.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • BioGeneriX AG
    • Neose Technologies, Inc.
UsernamePublicRestriction

Register